Fractyl Health (GUTS) Non-Current Assets (2023 - 2026)
Fractyl Health's (GUTS) quarterly Non-Current Assets came in at $33.5 million in Q1 2026, down 7.03% YoY from $36.0 million in Q1 2025, and down 1.07% on a QoQ basis from $33.8 million in Q4 2025.
Fractyl Health (GUTS) Non-Current Assets (2023 - 2026) Analysis & Trends
Fractyl Health (GUTS) has 4 years of Non-Current Assets data on file, last reported at $33.5 million in Q1 2026.
- Quarterly Non-Current Assets fell 7.03% year-over-year to $33.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $137.2 million (down 9.43% YoY) and the FY2025 annual result came in at $33.8 million, down 6.85% from the prior year.
- Non-Current Assets retreated to $33.5 million in Q1 2026, from $33.8 million in the prior quarter.
- In the past five years, Non-Current Assets ranged from a high of $40.6 million in Q4 2023 to a low of $33.5 million in Q1 2026.
- A 4-year average of $36.8 million and a median of $36.2 million in 2024 frame the typical range for Non-Current Assets.
- The widest YoY moves for Non-Current Assets: up 6.85% in 2025, down 11.98% in 2025.
- Tracing GUTS's Non-Current Assets over 4 years: stood at $40.6 million in 2023, then fell by 10.48% to $36.3 million in 2024, then slipped by 6.85% to $33.8 million in 2025, then slipped by 1.07% to $33.5 million in 2026.
- The last three Non-Current Assets figures came in at $33.5 million (Q1 2026), $33.8 million (Q4 2025), and $34.6 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 14.88 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 23.28 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | 1.96 Bn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | 5.15 Bn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 1.96 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 938.60 Mn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 468.65 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 18.06 Bn |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | 6.80 Bn |
| 10 | Fractyl Health | 109.12 Mn | 109.12 Mn | - | 32.37 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 32.37 Mn |
| Mar 31, 2026 | 33.47 Mn |
| Dec 31, 2025 | 33.83 Mn |
| Sep 30, 2025 | 34.57 Mn |
| Jun 30, 2025 | 35.32 Mn |
| Mar 31, 2025 | 36.00 Mn |
| Dec 31, 2024 | 36.31 Mn |
| Sep 30, 2024 | 39.27 Mn |
| Jun 30, 2024 | 39.88 Mn |
| Mar 31, 2024 | 39.05 Mn |
| Dec 31, 2023 | 40.56 Mn |